Banco BPM Merger Talks Mandate Puts Shareholder Compensation at the Center of Deal
Key Facts
Banco BPM’s board on November 12 authorized Chief Executive Giuseppe Castagna to begin discussions with Crédit Agricole on a merger proposal, according to Reuters. The decision moved the proposal into negotiations, with the bank making the deal’s impact on shareholder rights a central issue. The board said the transaction could create a prominent banking group, but would strip Banco BPM of its appeal as a takeover target. It added that shareholders would need to be compensated appropriately for that change. The issue, in the bank’s view, is the value shareholders would receive in exchange for giving up the bank’s independence and its potential to enter another takeover process.
The board linked any assessment of the proposal to the loss of the bank’s takeover potential and the strengths of its business model, according to Radiocor as reported by Borsa Italiana. It also said the valuation terms should secure the broadest possible support among shareholders. That means the discussion will cover not only the size of the combined entity or expected operating benefits, but also how value would be distributed between the two parties. The proposal includes Banco BPM paying an extraordinary dividend of 1 billion euros before the merger and valuing the bank at a 20% premium to Crédit Agricole Italia. These terms make compensation and valuation direct parts of the negotiations authorized by the board.
Crédit Agricole holds a 29.6% stake in Banco BPM, according to a Reuters report published on November 12. The proposal would give the French group a stake of about 45% in the combined entity. The two banks together would form Italy’s third-largest banking group, Reuters reported. The proposal also estimated annual benefits from the combination at about 800 million euros. Those expected gains sit alongside Banco BPM’s concern that the bank would lose its appeal as an independent target, explaining why its board stressed that the valuation should reflect the strengths of its business model and the loss of its takeover potential.
The proposal requires approval under Italy’s “whitewash” procedure, according to Reuters. Under this process, minority investors must approve the deal for Crédit Agricole to exceed the mandatory takeover threshold without making an offer to buy all of Banco BPM. The proposed structure’s viability therefore depends on those shareholders’ position, as well as on reaching a valuation acceptable to Banco BPM’s board. This puts minority support at the heart of the deal’s procedural path, rather than leaving it to a later stage. Reuters’ report did not give a date for a shareholder vote or a timetable for completing the transaction.
Crédit Agricole described the proposal as friendly at this stage and said it aims to combine retail banking and insurance activities, according to Reuters via MarketScreener. But the deal has drawn Italian government scrutiny because of strategic assets, including savings management and sovereign bonds. Italy’s “golden powers” rules allow the government to impose conditions on or block transactions deemed strategically important. Asset manager Anima has also featured in the discussion: Reuters reported on November 11 that Crédit Agricole had expressed openness to selling it as part of the deal. A Banco BPM spokesman said that possibility was unfounded, adding that the bank had no intention of selling it.
Anima manages more than 200 billion euros in assets and has been among the major buyers of Italian government bonds through its funds, according to Reuters. Its scale gives it significance in any discussion of the deal’s structure and its links to savings management and sovereign bonds. In the market, CRARY shares closed at 8.8 dollars on November 11, 2026, according to EL7 data. The available data do not include the session’s high and low prices. The next step in negotiations is to develop terms that reflect Banco BPM’s board’s position on compensation and valuation, while taking minority shareholder approval and government scrutiny into account; the available evidence did not specify a timetable for these steps.